Inspire Medical (NYSE: INSP) today announced clinical outcomes data for its latest-generation Inspire V neuromodulation ...
An Abbott (NYSE: ABT) official posted on social media to announce FDA breakthrough device designation for a new ablation ...
Pulse Biosciences (Nasdaq:PLSE) today announced clinical study results from a first-in-human study of its nPulse system.
Johnson & Johnson MedTech today introduced the Collaborative Outcomes Registry for Evidence in Ventricular Arrhythmias (CORE-VA).